Complex treatment of urogenital disorders using bioresonance

Dr. Cornelia Schumacher, MD. TM Ph.D dipl. PT for Urogenital Rehabilitation, St. Moritz, Switzerland

Foreword

Ladies and gentlemen Mr and Mrs Brugemann

After 14 years of clinical work in the field of physiotherapy/physio-science, in 1988 I was confronted with a new challenge: the treatment of conditions and complaints in the fields of gynaecology, urology, proctology, and psychology. Complaints such as urinary incontinence, faecal incontinence, constipation, impotence, prostate disorders, sexual diseases and problems in pregnancy were at the time taboo and called for great sensitivity when it came to their rehabilitation. The complexity of the matter resulted in my founding the specialist field “Urogenital Rehabilitation” in Switzerland. Treatments consisted by and large of pelvic floor exercises, biofeedback, electro stimulation “TENS” (Transcutaneous Nerve Stimulation) and intravaginal and intra-anal palpation. In 2003 I learned about the biophysical treatment option using BICOM® bioresonance, which I have been using successfully ever since in my urogynaecological and complementary medical practice. Since 1999 I have been self-employed. My practice, which was initially established in Lucerne and Stans, moved to St. Moritz in the beautiful Upper Engadin valley in 2012.

1 Urogenital rehabilitation

The term “urogenital rehabilitation” is derived from two specialisms, urology and the specialist medical field covering the organs responsible for urinary elimination and urine formation.

2 Clinical pictures and their treatment forms

“Urological rehabilitation” consists of a broad spectrum of clinical pictures. And their treatment options are just as extensive. In this work I am focusing therefore on a small number of therapeutic measures within the framework of bioresonance.

2.1 Urinary incontinence: the disease no one likes to talk about

Bladder weakness is extremely common and can be described as a truly widespread condition. Worldwide more than 200 million people are affected. In Switzerland bladder weakness is one of the most widespread health problems. According to estimates, at least 400,000 people of every age are sufferers in our country. With increased life expectancy we may safely assume that in the future more and more people will suffer from bladder weakness (Swiss Society for Bladder Weakness, 2013). The following types of urinary incontinence can be differentiated:

2.1.1 Clinical pictures of urinary incontinence

Stress incontinence / incontinence during physical activity

With this form of incontinence, which mainly affects women, there is an involuntary loss of urine during sudden physical exertion such as coughing, sneezing, laughing or lifting heavy loads. The quantities of urine lost can vary from 5 to 30m1 per episode. The extent to which people are affected by the physical inconvenience, and each individual’s differing sensitivity threshold for impaired quality of life, will vary depending on social circumstances.

The cause of this type of incontinence is a weakness in the pelvic floor muscles (pfm). A weakness in the pelvic floor muscles can be triggered by difficult births, forceps delivery, breech presentation, untrained pushing during labour, very rapid onset of labour, pfm trauma, tears in the

M. transversus perinei superficialis and profundus, and a tear in the Centrum tendineum perinei (Chakra 1).

Collagen connective tissue weakness, age and weakness from inactivity, oestrogen deficiency and the menopause are other factors impeding the functionality of the pelvic floor muscles (pfm) especially the M. levator ani and the M. sphincter ani extenus with the following possible consequences — loss of continence, cystocele, rectocele, prolapse, pain and social withdrawal.


Female pelvic floor muscles

Female pelvic floor muscles

The male pelvic floor muscles

The male pelvic floor muscles


Reflex incontinence
Reflex incontinence can be caused by diseases or injuries to the central or peripheral nervous system. Here, the corresponding nerve paths in the central nervous system, which are responsible for emptying the bladder, are interrupted. The bladder and sphincter muscle function can no longer be coordinated and controlled voluntarily.

Overflow incontinence
Overflow incontinence is the most frequent form of bladder weakness in men. Compared with other forms of incontinence, it is not a disorder of urine retention but a disorder related to emptying the bladder. It can be a consequence of prostate enlargement (prostate hyperplasia) or a bladder tumour. The urethra becomes increasingly constricted because of the demand on space on the urethra from the prostate gland and as such no longer allows a normal flow of urine during urination. Drops of urine escape and there is an urge to urinate with frequent urination (as many as 20 times in 24 hours). Frequent night time urination is significant with small amounts of urine (5-20m1/per miction).

Irritable bladder (hyperactive bladder)
This form of incontinence is triggered by over-excitability of the bladder muscle
(M. detrusor). The classic symptoms are frequent trips to the toilet during the day (pollakisuria), and often at night too (nykturia). In this case there is a strong and uncontrollable (imperative) urge to urinate and an involuntary and spontaneous loss of larger quantities of urine.

The causes for this are frequent urinary infections (cystitis), chronic inflammatory diseases, affliction with parasites, Candida, restricted retention capacity of the bladder because of bladder stones, tumours, cysts and hormonal changes. Also a urethral stricture (narrowing of the urethra) as occurs in male prostate hyperplasia, can lead to a reactive thickened and hyper excitable bladder muscle.

Overexcitability of the bladder muscle can however also have an idiopathic origin or be a consequence of an underlying neurological disease such as Parkinson’s disease, multiple sclerosis, diabetes mellitus or dementia. The underlying cause in such cases is considered to be damage to the neural control of the peripheral nerve fibres. The M. detrusor and the

M. sphincter urethrae externus (of the bladder) can no longer be controlled involuntarily (nerve root: spinal segments S2 —S4).

Cystitis (Inflammation of the bladder)
Uncomplicated acute cystitis is a disease of children and women. Men are usually only affected in connection with diseases of the bladder (tumour, stone) or prostate gland (obstruction). Typical acute cystitis in woman arises because of an increase in microbes in the urethra or also after sexual intercourse (so-called honeymoon cystitis). Factors which favour the situation are reduced immunity of the urethra mucous membrane (hormonal influences, chronic inflammation, radiation, immunodeficiency) as well as residual urine, foreign bodies or stones.

Symptoms of acute cystitis are the frequent urge to urinate producing small quantities of urine, pain and/or burning sensation when passing water. Visible blood (macrohaematuria) may occur, together with the above-named symptoms. Acute cystitis is a bacterial condition, usually the result of infection with the Escherichia coli (E. coli) bacterium, part of normal intestinal flora.

Interstitial cystitis affects older women and in time, because of structural changes to the bladder wall, leads to reduced bladder capacity. The aetiology is unknown. Besides autoimmune processes and neurogenic factors, it is known that infectious pathogens such as Chlamydia, ureaplasmas and mycoplasmas, gardnerella and viruses play a part. Since these germs occur in urethral syndrome, it is this that should be treated primarily. In rare cases symptomatic therapies are indicated for interstitial cystitis, such as bladder stretching, (controlled miction straining and miction analysis) and treatment with medication. (Urology clinic, Berne University Hospital (Inselspital) 2013).

2.1.2 Treatment approach

In my practice I take a detailed medical history for each patient, do a biophysical status, a physical examination and keep a miction diary.

In Appendix 5.1 you will find the “Urogynaecology” medical history sheet, which the patient fills out before the first consultation.

In Appendix 5.2 you will find the “Urogynaecological Diagnosis Sheet”. If you are unable to carry out the vaginal/ anal examinations yourself, have a doctor provide you with information on the relevant parameters.

In Appendix 5.3 you will find an information sheet on avoiding urinary tract infections, which will help you to give the appropriate recommendations to the patient.

Appendix 5.4 provides a template for a miction diary.

It is urgent that a record of miction be kept in the case of all bladder problems for several days over a 24 hour period. Information about drinking habits is also imperative with respect to bioresonance therapy and the transmission of biophysical information.

Testing and therapy procedures are carried out using the BICOM BICOM optima®.

3 Fundamental therapeutic procedures with bioresonance

Testing

Testing

Treatment systems
1. Basic therapy based on conductance reading

2. Treatment of blockages

Treatment of blockages

It is imperative during initial treatment not to forget scar interference elimination for navel, tonsillectomy, episiotomy, Caesarean section and vasectomy scars! Apply bioresonance oil in the output cup and rub in to the appropriate area.

3. Toxin eliminating organs

Toxin eliminating organs

4. Therapy for pathogenic substances following testing

Therapy for pathogenic substances following testing* Enterobius vermicularis and Schistosoma haematobium
** after individual testing

5. Urine therapy

To relieve and calm the bladder in the case of cystitis irritable and hyperactive bladder.

Urine therapy

* Note: Patient’s own fresh urine: mixed with a pinch of copper sulphate, (1d1 +/—) urine in the input cup, square applicator on the bladder connected to the red output cable.
** Nystatin/Multilind suspension and Mycolog ointment in the input cup, square applicator on the bladder connected to the red output cable.

6. Additional indicated therapy sequences

Additional indicated therapy sequences

* Tip: Hormone ampoule with native progesterone and oestradiol (Dr.med. Rohrer), oscillate in channel 2 after amplification.

7. Manual measures

 Manual measures

Cupping zones

Cupping zones

3.2 Erectile Dysfunction (Impotence)

When a man wants to but can’t.

3.2.1 Clinical picture

Erectile dysfunction (ED) is the inability of a man to achieve an erection for sexual intercourse, to penetrate the vagina and be able to successfully complete sexual intercourse. Results of a survey in the USA from 1987-1989 (the “Massachusetts Male Ageing Study”) have shown that more than 50% of all American men aged between 40 and 70 complained of erectile dysfunction with varying degrees of severity, with 34% of respondents reporting severe or moderate dysfunction. Erectile dysfunction poses a problem worldwide and affects highly developed industrial countries just as much as so-called civilised countries. Erectile dysfunction occurs much more frequently in diabetics, patients with high blood pressure, coronary heart disease, raised cholesterol and who have a heavy nicotine consumption. While it was believed earlier that erectile dysfunction is due to psychological reasons in more than 90% of cases, it is now known through modern investigative procedures that organic factors are responsible in the majority of all impotent men (60-80%) for their “failure” in bed and in particular disorders of the circulation in the erectile tissue underlying what is often generalised vascular disease. In this context, various authors, only in the last few years, have demonstrated that incidence of erectile dysfunction is very often associated with a concomitant disease of the coronary arteries (impending myocardial infarction) while the patient is often unaware of this disease since up to this point in time it has not produced any clinical symptoms. (Key term: Erectile dysfunction = endothelial dysfunction; Prof. Dr. med. Hartmut Porst, Urologist, Hamburg, 2012).

Human Anatomy

Leonardo da Vinci
1bc13829e3239383f1603f45b0712728

3.2.2 Treatment approach

Testing

See Chapter 1.1.2

Treatment systems

See Chapter 1.1.2 for the first four steps.

1. Basic therapy based on conductance reading
2. Treatment of blockages
3. Toxin eliminating organs
4. Therapy for pathogenic substances following testing.

5. Specific erectile dysfunction

Specific erectile dysfunction

Oscillate medication to encourage potency: Viagra, Levitra,
medicinal mushrooms (Lentinula edodes = Shiitake and Ganoderma lucidum = Ling Zhi, Reishi), drugs brought in by the patient, testosterone in the input cup. Alternatively tested in channel 2 for intensity and oscillated on to resonance drops, chip, globuli.

6. Manual measures

Tens (Transcutaneous and intra-anal electrostimulation) 1-10 Hz, comfortable intensity.


3.3 Induratio penis plastica (IPP)

3.3.1 Clinical picture

Induratio penis plastica involves dorsal, ventral or lateral curvature of the penis with chronic disease of both areas of erectile tissue, leading to scarring (plaques). Although the disease was first described in detail in1743 by the French surgeon Francois de la Peyronie, there has to date been little or no research into the causes.

At the present time there is general agreement among experts that Peyronie’s disease involves a multifactorial disease process, i.e. a number of factors may lead to manifestation. There is much evidence that repeated unnoticed micro-injuries to the dense white membrane (the tunica albuginea) covering the erectile tissue or the partition (septum) of the erectile tissue, can trigger induratio penis plastica. In the corresponding segments of erectile tissue involved, there is a so-called build up of plaque in the connective tissue layer with nodular induration of the tissue. This is similar to and comparable with Dupuytren’s contracture of the hand, where “shrinkage” is seen at the site affected, i.e. bending of the joint. With early diagnosis and treatment surgery can be avoided (Prof. Dr. Hartmut Porst, Urologist, Hamburg, 2012).

3.3.2 Treatment approach

Testing

See Chapter 1.1.2

Treatment systems

See Chapter 1.1.2 for the first four steps.

1. Basic therapy based on conductance reading
2. Treatment of blockages
3. Toxin eliminating organs
4. Therapy for pathogenic substances following testing.

5. Specific induratio penis plastica (IPP)

Specific induratio penis plastica (IPP)

The area to be treated on the penis is rolled with the roller applicator applying gentle pressure to produce a massaging effect. The patient can also carry this out himself.

For hyperaemisation of the penis, especially in the plaque-forming region, oscillate via channel 2 potency enhancing drugs on resonance oil (see Impotence). The oil should be massaged well into the plaque regions on a daily basis.

Alternatively it is recommended to oscillate via channel 2 stored substances, musculoskeletal system, symptom complex: Dupuytrens’ contracture.

With regard to treatment frequency, I treat chronic complaints once a week. For more acute cases such as painful urinary tract infections 2-3x a week. In principle my patients always come for a minimum of

6 to 20 treatment sessions.

Since patients find the treatments to be extremely pleasant and the success of the therapy is very quickly noticeable, my patients very often consult me after successful therapy on other ‘health-related’ matters.

A real advantage of bioresonance therapy compared with conventional treatment is its pleasant application, the work with the patient’s own frequency patterns, substrates and the organ-related therapeutic procedure.

4 Closing word

The field of urogenital diseases and their treatment is extremely complex.

I hope I have succeeded in raising awareness of this important and often taboo area of medicine and its ethics.

The use of bioresonance therapy is a valuable instrument in helping and healing these sensitive conditions.

Dr. Cornelia Schumacher Institute Tel/Fax: +41 (0) 81 833 33 37
Email: praxis@cornelia-schumacher.ch
www.cornelia-schumacher.ch

5 Appendix

5.1 Urogynaecology Medical History Sheet

Urogynaecology Medical History Sheet

5.2 Urogynaecological Diagnosis Sheet

Urogynaecological Diagnosis Sheet

5.3 Information Sheet Avoiding Urinary Tract Infections

Information Sheet
Avoiding repeated urinary tract infections.

Dear Patient,
You are suffering from repeated bladder infections. These infections usually occur because intestinal bacteria reach the urethra via the vagina and from the urethra get into the bladder causing an infection with the typical symptoms. Typical symptoms are a burning sensation when passing water, frequent urge to urinate, bladder pain and bad-smelling urine or urine leakage. It is normal for intestinal bacteria to occur near the vagina and the urethra. But in your case there appears to be a localised lowered resistance in the urethra or bladder so that bacteria there cannot be removed by the body on its own. By changing habits you may be able to improve your defence against infection and prevent the bacteria from entering the bladder.

The following changes in habits and measures are advisable (the steps applicable to you are marked with a cross):

Treatment program
Treatment program

5.4 Miction diary


Miction diary

5.6 Pelvic viscera and perineum in women

Pelvic viscera and perineum in women

pdf download button